Status:
RECRUITING
Green Light and Transcranial Direct Current Stimulation in Migraine Patients
Lead Sponsor:
Riphah International University
Conditions:
Migraine
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
There is a lack of evidence on the clinical outcome of green light exposure, as it is the emerging, novel proposal of treatment. There are a lot of researches present with small sample size which shou...
Detailed Description
Migraine treatments encompass both medicinal options, such as acute and preventive medications, as well as a variety of non-pharmacological therapies. The range of acute medications that are available...
Eligibility Criteria
Inclusion
- Meet the diagnostic criteria established by the International Headache Society,
- patient must have had at least 5 headache attacks that lasted 4-72 hours (untreated or unsuccessfully treated)
- headache must have had at least 2 of the following characteristic; Unilateral location \& Pulsating quality,
- An average headache pain intensity of migraine episodes of ≥5 at numeric pain scale (NPS) over the 10 weeks prior to enrolling in the study.
Exclusion
- Mental illness,
- Photophobic individual,
- Presence of shunt and/or implant at the cranial region,
- Brain tumors,
- Wound at skull
Key Trial Info
Start Date :
January 18 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 31 2024
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT06212869
Start Date
January 18 2024
End Date
October 31 2024
Last Update
March 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pakistan Railway General Hospital
Rawalpindi, Punjab Province, Pakistan